Magnetization transfer ratio in gray matter: a potential surrogate marker for progression in early primary progressive multiple sclerosis.
暂无分享,去创建一个
Mara Cercignani | Olga Ciccarelli | Alan J Thompson | O. Ciccarelli | A. Thompson | M. Cercignani | D. Altmann | Z. Khaleeli | David H Miller | Daniel R Altmann | Zhaleh Khaleeli | David H. Miller | A. Thompson
[1] Mara Cercignani,et al. Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study. , 2005, Brain : a journal of neurology.
[2] P. Sørensen,et al. Erratum: Remyelination is extensive in a subset of multiple sclerosis patients (Brain (2006) 129, PART 12, (3165-3172) DOI: 10.1093/brain/awl217) , 2007 .
[3] R. Prentice. Surrogate endpoints in clinical trials: definition and operational criteria. , 1989, Statistics in medicine.
[4] P. Tofts. Quantitative MRI of the Brain , 2003 .
[5] Bruce D. Trapp,et al. Pathogenesis of axonal and neuronal damage in multiple sclerosis , 2007, Neurology.
[6] F. Barkhof,et al. Long-term clinical outcome of primary progressive MS: Predictive value of clinical and MRI data , 2005, Neurology.
[7] M. Rovaris,et al. Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis. , 2006, Brain : a journal of neurology.
[8] F Barkhof,et al. The role of MRI as a surrogate outcome measure in multiple sclerosis , 2002, Multiple sclerosis.
[9] Hans Lassmann,et al. Remyelination is extensive in a subset of multiple sclerosis patients. , 2006, Brain : a journal of neurology.
[10] D. Paty,et al. The natural history of primary progressive MS in British Columbia, Canada , 2005, Neurology.
[11] B. Trapp,et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.
[12] G. Barker,et al. Sources of variation in multi-centre brain MTR histogram studies: body-coil transmission eliminates inter-centre differences , 2006, Magnetic Resonance Materials in Physics, Biology and Medicine.
[13] David H. Miller,et al. Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain , 2004, Annals of neurology.
[14] Massimo Filippi,et al. MRI to Monitor Treatment Efficacy in Multiple Sclerosis , 2007, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[15] M. Versavel,et al. Can the Expanded Disability Status Scale be assessed by telephone? , 2003, Multiple sclerosis.
[16] Hans Lassmann,et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. , 2005, Brain : a journal of neurology.
[17] Marco Rovaris,et al. Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study. , 2003, Brain : a journal of neurology.
[18] B. Brownell,et al. The distribution of plaques in the cerebrum in multiple sclerosis , 1962, Journal of neurology, neurosurgery, and psychiatry.
[19] J. L. Cox,et al. Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case–control study , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[20] A J Thompson,et al. Diagnostic criteria for primary progressive multiple sclerosis: A position paper , 2000, Annals of neurology.
[21] Rohit Bakshi,et al. Gray matter involvement in multiple sclerosis , 2007, Neurology.
[22] A J Thompson,et al. Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: a tissue specific magnetisation transfer study , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[23] Z Khaleeli,et al. Magnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosis , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[24] M Rovaris,et al. Evidence for progressive gray matter loss in patients with relapsing-remitting MS , 2005, Neurology.
[25] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[26] A. Thompson,et al. Cord atrophy separates early primary progressive and relapsing remitting multiple sclerosis , 2006, Journal of Neurology, Neurosurgery & Psychiatry.
[27] Frederik Barkhof,et al. Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. , 2005, AJNR. American journal of neuroradiology.
[28] P. Narayana,et al. Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double‐blind, placebo‐controlled trial , 2007, Annals of neurology.
[29] M. Rovaris,et al. A new method for analyzing histograms of brain magnetization transfer ratios: comparison with existing techniques. , 2004, AJNR. American journal of neuroradiology.
[30] A. J. Thompson,et al. Localized grey matter damage in early primary progressive multiple sclerosis contributes to disability , 2007, NeuroImage.
[31] G. Ebers. Natural history of primary progressive multiple sclerosis , 2004, Multiple sclerosis.
[32] J H Simon,et al. Brain atrophy in multiple sclerosis: what we know and would like to know , 2006, Multiple sclerosis.
[33] Alan J. Thompson,et al. Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosis , 2004, NeuroImage.